✦ LIBER ✦

A phase II study of cisplatin in advanced gastric cancer

✍ Scribed by Beer, Meyir; Cocconi, Giorgio; Ceci, Guido; Varini, Marco; Cavalli, Franco

Book ID: 123128100
Publisher: Elsevier Science
Year: 1983
Weight: 381 KB
Volume: 19
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(83)90003-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of S-1 combined with ci

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

✍ Koizumi, W; Tanabe, S; Saigenji, K; Ohtsu, A; Boku, N; Nagashima, F; Shirao, K; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

A phase ii study of the combination of e

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

✍ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc

A randomised phase II study of combinati

A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer

✍ Jina Yun; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

224 Docetaxel and cisplatin combination

224 Docetaxel and cisplatin combination chemotherapy in patients with advanced or metastatic gastric cancer: results of a multicentre phase II study

✍ J. Fahlke; K. Ridwelski; E. Kettner; U. Keilholz; C. Schmidt; K. Eichelmann; H. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

A phase I/II study of S-1 plus cisplatin

A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen

✍ Yasuhiro Sato; Hitoshi Kondo; Kana Honda; Daisuke Takahari; Tetsuya Sumiyoshi; Y 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 208 KB

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB